Hamburger Institut für Therapieforschung GmbH (HIT)
About Hamburger Institut für Therapieforschung GmbH (HIT)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hamburger Institut für Therapieforschung GmbH (HIT)
During the past decade, Hamburger Institut für Therapieforschung GmbH (HIT) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
2009-09-01
2011-09-01
Completed
74,256
Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V
2010-06-01
2010-09-01
Completed
1,200
Rib Fixation for Clinically Severe Rib Fractures From Trauma
2015-04-01
2023-12-01
Recruiting
236
Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
2016-04-26
2023-12-01
Active, not recruiting
271
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hamburger Institut für Therapieforschung GmbH (HIT)"
#1 collaborator was "Hannover Medical School" with 2 trials as a collaborator, "Philipps University Marburg Medical Center" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "German Center for Lung Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hamburger Institut für Therapieforschung GmbH (HIT)
According to Clinical.Site data, the most researched conditions in "Hamburger Institut für Therapieforschung GmbH (HIT)" are
"Asthma" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Chronic Obstructive Pulmonary Disease (COPD)" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Hamburger Institut für Therapieforschung GmbH (HIT)" in a lesser frequency.
Clinical Trials Intervention Types at Hamburger Institut für Therapieforschung GmbH (HIT)
Most popular intervention types in "Hamburger Institut für Therapieforschung GmbH (HIT)" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (1 trials), "Tiotropium + olodaterol" (1 trials), "placebo" (1 trials) and "risankizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hamburger Institut für Therapieforschung GmbH (HIT)
The vast majority of trials in "Hamburger Institut für Therapieforschung GmbH (HIT)" are
4 trials for "All" genders.
Clinical Trials Status at Hamburger Institut für Therapieforschung GmbH (HIT)
Currently, there are NaN active trials in "Hamburger Institut für Therapieforschung GmbH (HIT)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 3 completed trials in Hamburger Institut für Therapieforschung GmbH (HIT),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hamburger Institut für Therapieforschung GmbH (HIT), 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".